Targeting Inflammasome Activation in Viral Infection: A Therapeutic Solution?
- PMID: 37515138
- PMCID: PMC10384481
- DOI: 10.3390/v15071451
Targeting Inflammasome Activation in Viral Infection: A Therapeutic Solution?
Abstract
Inflammasome activation is exclusively involved in sensing activation of innate immunity and inflammatory response during viral infection. Accumulating evidence suggests that the manipulation of inflammasome assembly or its interaction with viral proteins are critical factors in viral pathogenesis. Results from pilot clinical trials show encouraging results of NLRP3 inflammasome suppression in reducing mortality and morbidity in SARS-CoV-2-infected patients. In this article, we summarize the up-to-date understanding of inflammasomes, including NLRP3, AIM2, NLRP1, NLRP6, and NLRC4 in various viral infections, with particular focus on RNA viruses such as SARS-CoV-2, HIV, IAV, and Zika virus and DNA viruses such as herpes simplex virus 1. We also discuss the current achievement of the mechanisms involved in viral infection-induced inflammatory response, host defense, and possible therapeutic solutions.
Keywords: host defense; inflammasome; inflammatory response; innate immunity; therapy; viral infection.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Inflammasomes on the Crossroads of Innate Immune Recognition and Metabolic Control.Cell Metab. 2017 Jul 5;26(1):71-93. doi: 10.1016/j.cmet.2017.06.018. Cell Metab. 2017. PMID: 28683296 Review.
-
DDX3X coordinates host defense against influenza virus by activating the NLRP3 inflammasome and type I interferon response.J Biol Chem. 2021 Jan-Jun;296:100579. doi: 10.1016/j.jbc.2021.100579. Epub 2021 Mar 23. J Biol Chem. 2021. PMID: 33766561 Free PMC article.
-
Zika virus infection induces host inflammatory responses by facilitating NLRP3 inflammasome assembly and interleukin-1β secretion.Nat Commun. 2018 Jan 9;9(1):106. doi: 10.1038/s41467-017-02645-3. Nat Commun. 2018. PMID: 29317641 Free PMC article.
-
Inflammasomes during SARS-CoV-2 infection and development of their corresponding inhibitors.Front Cell Infect Microbiol. 2023 Jun 9;13:1218039. doi: 10.3389/fcimb.2023.1218039. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37360532 Free PMC article. Review.
-
Innate Immune Response and Inflammasome Activation During SARS-CoV-2 Infection.Inflammation. 2022 Oct;45(5):1849-1863. doi: 10.1007/s10753-022-01651-y. Epub 2022 Aug 11. Inflammation. 2022. PMID: 35953688 Free PMC article. Review.
Cited by
-
Genetic Variants in the NOD-like Receptor Signaling Pathway Are Associated with HIV-1/AIDS in a Northern Chinese Population.Int J Mol Sci. 2025 Apr 8;26(8):3484. doi: 10.3390/ijms26083484. Int J Mol Sci. 2025. PMID: 40331958 Free PMC article.
-
Inflammasome-Related Genetic Polymorphisms as Severity Biomarkers of COVID-19.Int J Mol Sci. 2024 Mar 27;25(7):3731. doi: 10.3390/ijms25073731. Int J Mol Sci. 2024. PMID: 38612539 Free PMC article.
-
Targeting inflammasomes as an immunotherapeutic strategy for cancer.J Transl Med. 2025 Jun 8;23(1):634. doi: 10.1186/s12967-025-06665-2. J Transl Med. 2025. PMID: 40484954 Free PMC article. Review.
-
Regulation and functions of the NLRP3 inflammasome in RNA virus infection.Front Cell Infect Microbiol. 2024 Jan 5;13:1309128. doi: 10.3389/fcimb.2023.1309128. eCollection 2023. Front Cell Infect Microbiol. 2024. PMID: 38249297 Free PMC article. Review.
-
Pyroptosis: a new insight into intestinal inflammation and cancer.Front Immunol. 2024 Feb 22;15:1364911. doi: 10.3389/fimmu.2024.1364911. eCollection 2024. Front Immunol. 2024. PMID: 38455052 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous